Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
FEBS Letters
|
October 9, 1989
Photoaffinity labeling of the mammalian dopamine transporter
F R Sallee, E L Fogel, E Schwartz, et al.
Journal of Medicinal Chemistry
|
August 17, 1999
Novel A,B,E-ring-modified camptothecins displaying high lipophilicity and markedly improved human blood stabilities
D Bom, D P Curran, A J Chavan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 8, 2001
The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activity
D Bom, D P Curran, J Zhang, et al.
Journal of Medicinal Chemistry
|
October 29, 2000
The novel silatecan 7-tert-butyldimethylsilyl-10-hydroxycamptothecin displays high lipophilicity, improved human blood stability, and potent anticancer activity
D Bom, D P Curran, S Kruszewski, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
FEBS Letters
|
October 9, 1989
Photoaffinity labeling of the mammalian dopamine transporter
F R Sallee, E L Fogel, E Schwartz, et al.
Journal of Medicinal Chemistry
|
August 17, 1999
Novel A,B,E-ring-modified camptothecins displaying high lipophilicity and markedly improved human blood stabilities
D Bom, D P Curran, A J Chavan, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 8, 2001
The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activity
D Bom, D P Curran, J Zhang, et al.
Journal of Medicinal Chemistry
|
October 29, 2000
The novel silatecan 7-tert-butyldimethylsilyl-10-hydroxycamptothecin displays high lipophilicity, improved human blood stability, and potent anticancer activity
D Bom, D P Curran, S Kruszewski, et al.
Page
of 3